Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Katkin Keith, Director. Officer active across 6 companies, notably RIGEL PHARMACEUTICALS INC. Cumulatively, 15 reports have been recorded. Split: 1 buy · 1 sell. Total volume traded: €125k. Activity tracked since 19 May 2021. The latest transaction was filed on 4 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Katkin Keith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Katkin Keith is Administrateur and reports transactions in Syndax Pharmaceuticals Inc, Emergent BioSolutions Inc., Eledon Pharmaceuticals, Inc. and RIGEL PHARMACEUTICALS INC. The record shows 15 filings, and across the 15 sampled filings the stated aggregate amounts are EUR 81115 of buys and EUR 43802 of sells, over the period from 2021-05-21 to 2026-02-06.